Back to Home

Multidisciplinary Insights to Enhance Biomarker Testing Practices in Non-Small Cell Lung Cancer

October 15, 2025 | 7:00 PM EDT

Countdown to Event

00

Days

00

Hours

00

Mins

00

Secs

Stream Link: https://event.arraylive.com/app/login/bfb299ac-b183-4186-bd55-dcdef040159f/virtualattendee


Program Description

Pharmacists play a critical role in the clinical integration of biomarker testing and pharmacogenomics to advance personalized treatments. This multidisciplinary panel discussion is designed to translate knowledge and evidence into actionable solutions for real-world practice. Experts will debate and discuss common barriers to optimal biomarker testing in non-small cell lung cancer (NSCLC), from guideline updates to the specific challenges presented by different NSCLC subtypes. The panel will then highlight examples of interventions that could be implemented to improve testing practices and patient outcomes, ranging from standardized recommendations for testing and the development of precision medicine services involving oncology pharmacists. Finally, the panelists will share best practices and institutional tools that have optimized biomarker testing workflows as well as best practices for clinical review processes to ensure timely and accurate information to guide treatment selection. Through a discussion of their own successes, the panelists will offer practical insights and recommendations for implementing quality improvement and process changes that other institutions can adapt to overcome barriers and enhance the delivery of precision care in NSCLC.

    Event Details

    • Start Date
      Wednesday, October 15, 2025 | 7:00 PM EDT
    • End Date
      Wednesday, October 15, 2025 | 8:00 PM EDT
    • Location
      Virtual
    • Target Audience
      Oncology Pharmacist

    This activity is supported by independent medical educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly.

    Related Content